Methoxypropane
|
|
| Names
|
| Preferred IUPAC name
|
| Other names
Propane, 1-methoxy- methyl propyl ether Metopryl Neothyl propane, 1-methoxy methyl n-propyl ether
|
| Identifiers
|
CAS Number
|
|
3D model (JSmol)
|
|
| ChemSpider
|
|
| ECHA InfoCard
|
100.008.327
|
| EC Number
|
|
|
|
|
| RTECS number
|
|
| UNII
|
|
| UN number
|
2612
|
|
|
|
InChI=1S/C4H10O/c1-3-4-5-2/h3-4H2,1-2H3 Y Key: VNKYTQGIUYNRMY-UHFFFAOYSA-N Y InChI=1/C4H10O/c1-3-4-5-2/h3-4H2,1-2H3
|
|
|
| Properties
|
Chemical formula
|
C4H10O
|
| Molar mass
|
74.12
|
| Density
|
0.7356 g/cm3
|
| Boiling point
|
38.8 °C (101.8 °F; 311.9 K)
|
Solubility in water
|
30.5 g/L
|
Refractive index (nD)
|
1.35837 (14.3 °C)
|
| Viscosity
|
0.3064 cP (0.3 °C)
|
| Pharmacology
|
|
|
inhalation
|
| Hazards
|
| NFPA 704 (fire diamond)
|
|
| Flash point
|
< −20 °C (−4 °F; 253 K)
|
| Explosive limits
|
1.9–11.8%
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
|
Methoxypropane, or methyl propyl ether, is an ether once used as a general anaesthetic.[1] It is a clear colorless flammable liquid with a boiling point of 38.8 °C.[2]
Marketed under the trade names Metopryl and Neothyl, methoxypropane was used as an alternative to diethyl ether because of its greater potency. Its use as an anaesthetic has since been supplanted by modern halogenated ethers which are much less flammable.
References
- ^ White, Mary Louise T.; Shane, Sylvan M.; Krantz, John C., Jr. "Anesthesia. XXI. Propyl methyl ether as an inhalation anesthetic in man", Anesthesiology, (1946), 7, 663-7.
- ^ Merck Index, 11th edition, 6031.
|
|---|
| Alcohols | |
|---|
| Barbiturates | |
|---|
| Benzodiazepines | |
|---|
| Carbamates | |
|---|
| Flavonoids |
- 6-Methylapigenin
- Ampelopsin (dihydromyricetin)
- Apigenin
- Baicalein
- Baicalin
- Catechin
- EGC
- EGCG
- Hispidulin
- Linarin
- Luteolin
- Rc-OMe
- Skullcap constituents (e.g., baicalin)
- Wogonin
|
|---|
| Imidazoles | |
|---|
| Kava constituents |
- 10-Methoxyyangonin
- 11-Methoxyyangonin
- 11-Hydroxyyangonin
- Desmethoxyyangonin
- 11-Methoxy-12-hydroxydehydrokavain
- 7,8-Dihydroyangonin
- Kavain
- 5-Hydroxykavain
- 5,6-Dihydroyangonin
- 7,8-Dihydrokavain
- 5,6,7,8-Tetrahydroyangonin
- 5,6-Dehydromethysticin
- Methysticin
- 7,8-Dihydromethysticin
- Yangonin
|
|---|
| Monoureides | |
|---|
| Neuroactive steroids | |
|---|
| Nonbenzodiazepines | |
|---|
| Phenols | |
|---|
| Piperidinediones | |
|---|
| Pyrazolopyridines | |
|---|
| Quinazolinones | |
|---|
| Volatiles/gases | |
|---|
| Others/unsorted |
- 3-Hydroxybutanal
- α-EMTBL
- AA-29504
- Alogabat
- Avermectins (e.g., ivermectin)
- Bromide compounds (e.g., lithium bromide, potassium bromide, sodium bromide)
- Carbamazepine
- Chloralose
- Chlormezanone
- Clomethiazole
- Darigabat
- DEABL
- Deuterated etifoxine
- Dihydroergolines (e.g., dihydroergocryptine, dihydroergosine, dihydroergotamine, ergoloid (dihydroergotoxine))
- DS2
- Efavirenz
- Etazepine
- Etifoxine
- Fenamates (e.g., flufenamic acid, mefenamic acid, niflumic acid, tolfenamic acid)
- Fluoxetine
- Flupirtine
- Hopantenic acid
- KRM-II-81
- Lanthanum
- Lavender oil
- Lignans (e.g., 4-O-methylhonokiol, honokiol, magnolol, obovatol)
- Loreclezole
- Menthyl isovalerate (validolum)
- Monastrol
- Nicotinic acid
- Nicotinamide
- Org 25,435
- Phenytoin
- Propanidid
- Retigabine (ezogabine)
- Safranal
- Seproxetine
- Stiripentol
- Sulfonylalkanes (e.g., sulfonmethane (sulfonal), tetronal, trional)
- Terpenoids (e.g., borneol)
- Topiramate
- Valerian constituents (e.g., isovaleric acid, isovaleramide, valerenic acid, valerenol)
|
|---|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |